Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab

Human leukocyte antigen class I (HLA‐I) genotypes are suggested to influence the cancer response to checkpoint blockade immunotherapy. This study assessed the impact of germline HLA genotypes on clinical outcomes in patients with chemoresistant advanced urothelial cancer (UC) treated with pembrolizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Shuhei, Narita, Shintaro, Fujiyama, Nobuhiro, Hatakeyama, Shingo, Kobayashi, Takashi, Kato, Renpei, Naito, Sei, Sakatani, Toru, Kashima, Soki, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Souhei, Numakura, Kazuyuki, Saito, Mitsuru, Obara, Wataru, Tsuchiya, Norihiko, Ohyama, Chikara, Ogawa, Osamu, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746062/
https://www.ncbi.nlm.nih.gov/pubmed/35848083
http://dx.doi.org/10.1111/cas.15488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746062/
https://www.ncbi.nlm.nih.gov/pubmed/35848083
http://dx.doi.org/10.1111/cas.15488

Ejemplares similares